Newswire

[ April 1, 2020 ] U.S. private payrolls post first decline since 2017 Business News
[ April 1, 2020 ] EU proposes short-time work scheme to avoid coronavirus lay-offs Business News
[ April 1, 2020 ] Futures tumble in start to second quarter as coronavirus crisis worsens Business News
[ April 1, 2020 ] Russia, U.S. hold energy talks, as Trump complains about oil cheaper than water Business News
[ April 1, 2020 ] Exclusive: Germany ready to nationalize airline Condor – sources Business News
[ April 1, 2020 ] Edited Transcript of ONTX earnings conference call or presentation 24-Mar-20 8:30pm GMT Trading Ideas
[ April 1, 2020 ] GUNDLACH WARNS: Stocks could 'take out' the March lows, economists' GDP forecasts are too optimistic Trading Ideas
[ April 1, 2020 ] Time To Worry? Analysts Just Downgraded Their Royal Caribbean Cruises Ltd. (NYSE:RCL) Outlook Trading Ideas
[ April 1, 2020 ] What Kind Of Share Price Volatility Should You Expect For JetBlue Airways Corporation (NASDAQ:JBLU)? Trading Ideas
[ April 1, 2020 ] Saudi Arabia Resists Trump’s Attempt to Broker Oil-War Truce Trading Ideas

CytoDyn (OTC: CYDY) Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

March 31, 2020 Comments Off on CytoDyn (OTC: CYDY) Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants
FDA Clears CytoDyn’s (OTC: CYDY) Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately

March 31, 2020 Comments Off on FDA Clears CytoDyn’s (OTC: CYDY) Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately
(OTC: CYDY) Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients

March 30, 2020 Comments Off on (OTC: CYDY) Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients
CytoDyn Files FDA-Suggested Modifications to IND and Protocol for Phase 2 Clinical Trial for COVID-19 Patients with Mild to Moderate Indications and a Second Randomized Protocol for All COVID-19 Patients in Severe Condition Will be Filed Next Week per FDA Recommendation

March 27, 2020 Comments Off on CytoDyn Files FDA-Suggested Modifications to IND and Protocol for Phase 2 Clinical Trial for COVID-19 Patients with Mild to Moderate Indications and a Second Randomized Protocol for All COVID-19 Patients in Severe Condition Will be Filed Next Week per FDA Recommendation
(OTC: CYDY) Leronlimab Used in Seven Patients with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU, Removed from ICU and Extubated with Reduced Pulmonary Inflammation

March 27, 2020 Comments Off on (OTC: CYDY) Leronlimab Used in Seven Patients with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU, Removed from ICU and Extubated with Reduced Pulmonary Inflammation
NexTech AR (OTC: NEXCF) Reports $6 million in Revenues for its Audited Period Ended December 31st 2019

March 27, 2020 Comments Off on NexTech AR (OTC: NEXCF) Reports $6 million in Revenues for its Audited Period Ended December 31st 2019

Investing Strategy

NexTech AR Solutions (OTC: NEXCF) Emerging leader in $120 billion Augmented Reality mega-trend. “Unicorn Farm” with multiple shots on goal/targeting multi-billion dollar market opportunities.

January 28, 2020 Comments Off on NexTech AR Solutions (OTC: NEXCF) Emerging leader in $120 billion Augmented Reality mega-trend. “Unicorn Farm” with multiple shots on goal/targeting multi-billion dollar market opportunities.

Analyst Notes NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR) REVISED Upside Potential Target: US$20.00 (next 12 months.) Current Stock Price: US$2.00 (January 28, 2020) Initial Discovery Report published: November 6, 2019 ($1.06) $5.00 upside target We are publishing this interim analyst note now, and anticipate publishing a [...]

How to Grow Your Business Exponentially – Patrick Bet-David

November 11, 2018 Comments Off

How to Grow Your Business Exponentially – Patrick Bet-David

The Secret to Exponential Growth: 4 Strategies to Grow Your Business

October 24, 2018 Comments Off

Patrick Bet-David explains the secret to exponential growth

“Google = Delusional Marxists” Tech Visionary George Gilder on the Blockchain Future “New Internet”

October 1, 2018 Comments Off

“Forget Big Data and delusional Google Marxists ” Visionary George Gilder talks about the future of the internet Life After Google – The New Blockchain Future

Brien Lundin: Epic BULL MARKET in GOLD & SILVER – Here’s How You Can Profit.

March 25, 2020 Comments Off on Brien Lundin: Epic BULL MARKET in GOLD & SILVER – Here’s How You Can Profit.
Brent Cook: How to PROFIT with Exploration Stocks – Gold Silver Battery Metals & More

March 13, 2020 Comments Off on Brent Cook: How to PROFIT with Exploration Stocks – Gold Silver Battery Metals & More
David Morgan: Silver $150 !! Gold $5,000 !! in next PARABOLIC bull run. Why YOU NEED SILVER now!

March 13, 2020 Comments Off on David Morgan: Silver $150 !! Gold $5,000 !! in next PARABOLIC bull run. Why YOU NEED SILVER now!
Wall Street Icon ASHER EDELMAN: Economy COLLAPSE + 2020 Election forecast

March 13, 2020 Comments Off on Wall Street Icon ASHER EDELMAN: Economy COLLAPSE + 2020 Election forecast
Mickey Fulp “Mercenary Geologist”: Bullish on SILVER. Plus: How to DOUBLE your money in resource exploration stocks

March 6, 2020 Comments Off on Mickey Fulp “Mercenary Geologist”: Bullish on SILVER. Plus: How to DOUBLE your money in resource exploration stocks
Peter Leeds: GOLD will soar to RECORD HIGHS (but SILVER will outperform).

March 6, 2020 Comments Off on Peter Leeds: GOLD will soar to RECORD HIGHS (but SILVER will outperform).
Marc Faber: Coronavirus changes society FOREVER! Plus: GOLD, stocks, interest rates, China & HK

March 5, 2020 Comments Off on Marc Faber: Coronavirus changes society FOREVER! Plus: GOLD, stocks, interest rates, China & HK

NexTech (OTC: NEXCF) Now a CORONAVIRUS “pure play” stock. AR + Remote Working / Training & Ecomm Positions NEXCF for Growth in 2020

March 18, 2020 Comments Off on NexTech (OTC: NEXCF) Now a CORONAVIRUS “pure play” stock. AR + Remote Working / Training & Ecomm Positions NEXCF for Growth in 2020
Imagination Part Technologies (OTC: IPNFF) (CSE: IP) Why AR Tech Adoption Can Get Boost From Coronavirus

March 11, 2020 Comments Off on Imagination Part Technologies (OTC: IPNFF) (CSE: IP) Why AR Tech Adoption Can Get Boost From Coronavirus
DEMO DAY! Augmented Reality GAME CHANGER! NexTech (OTC: NEXCF) Next Super Stock conference

March 6, 2020 Comments Off on DEMO DAY! Augmented Reality GAME CHANGER! NexTech (OTC: NEXCF) Next Super Stock conference
NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR) New AR Capture App = Catalyst for Explosive Revenue Growth

February 27, 2020 Comments Off on NexTech AR Solutions (OTC: NEXCF) (CSE: NTAR) New AR Capture App = Catalyst for Explosive Revenue Growth

Investor Presentations

FaceBank (OTC: FBNK) Merger with fuboTV = Streaming Powerhouse!

March 30, 2020 Comments Off on FaceBank (OTC: FBNK) Merger with fuboTV = Streaming Powerhouse!

FaceBank Group (OTC: FBNK) March 26, 2020 Next Super Stock conference presentation FaceBank Group (OTC: FBNK) CEO John Textor discusses the company’s upcoming merger with fuboTV – a live TV streaming platform with [...]
Investor Presentations

NexTech AR Solutions (OTC: NEXCF): Positioned to thrive in “Coronavirus economy” with AR, Ecommerce, Remote Work Apps

March 23, 2020 Comments Off on NexTech AR Solutions (OTC: NEXCF): Positioned to thrive in “Coronavirus economy” with AR, Ecommerce, Remote Work Apps

Next Super Stock – March 19, 2020 Livestream NEXT SUPER STOCK conference presenter NexTech AR Solutions (OTC: NEXCF) shares why NEXCF is oositioned to thrive in “Coronavirus economy” with AR, Ecommerce, Remote Work [...]
Healthcare

CytoDyn (OTC: CYDY) Coronaovirus Treatment gets FDA EMERGENCY IND + update on HIV & Cancer pipeline

March 23, 2020 Comments Off on CytoDyn (OTC: CYDY) Coronaovirus Treatment gets FDA EMERGENCY IND + update on HIV & Cancer pipeline

Next Super Stock – March 19, 2020 Livestream ABOUT THE EVENT NEXT SUPER STOCK Live! is Wall Street Reporter’s flagship investor conference series featuring presentations by a select group of companies [...]
Investor Presentations

Next Super Stock Imagination Park (OTC: IPNFF) (CSE: IP) February 12 Presentation

February 17, 2020 Comments Off on Next Super Stock Imagination Park (OTC: IPNFF) (CSE: IP) February 12 Presentation

Imagination Park (OTC: IPNFF) (CSE: IP) debuts at Wall Street Reporter’s Next Super Stock Livestream Conference CEO Alen Paul Silverrstieen shows how IPNFF’s is capitalizing on unique opportunities in the emerging $120 billion dollar Augmented [...]
Investor Presentations

FaceBank Group (OTC: FBNK) Next Super Stock Conference Presentation February 13, 2020

February 17, 2020 Comments Off on FaceBank Group (OTC: FBNK) Next Super Stock Conference Presentation February 13, 2020

FaceBank Group (OTC: FBNK) Next Super Stock Conference Presentation February 13, 2020 John Textor discusses the company’s “moonshot” goal to build and monetize the ultimate IP asset: all [...]
Healthcare

Next Super Stock CytoDyn, Inc. (OYTC: CYDY) – February 11, 2020 Livestream

February 12, 2020 Comments Off on Next Super Stock CytoDyn, Inc. (OYTC: CYDY) – February 11, 2020 Livestream

Next Super Stock – February 11, 2020 Livestream Presenter: CytoDyn, Inc. (OYTC: CYDY) Nader Pourhassan, Ph.D Back by popular demand! CytoDyn, Inc. (OTC: CYDY) CEO Nader Pourhassan, Ph.D, will be making a follow-up [...]

CytoDyn (OTC: CYDY) Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants

March 31, 2020 Comments Off on CytoDyn (OTC: CYDY) Completes Non-dilutive $15 Million Convertible Note Financing with Conversion Rate at $4.50 Per Share without Warrants
FDA Clears CytoDyn’s (OTC: CYDY) Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately

March 31, 2020 Comments Off on FDA Clears CytoDyn’s (OTC: CYDY) Phase 2 Randomized Trial to Treat Mild-to-Moderately Ill Coronavirus Patients with Leronlimab; Enrollment to Begin Immediately
(OTC: CYDY) Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients

March 30, 2020 Comments Off on (OTC: CYDY) Three Additional Patients with Severe COVID-19 Treated with Leronlimab in New York Medical Center Bringing the Total to 10 Patients
CytoDyn Files FDA-Suggested Modifications to IND and Protocol for Phase 2 Clinical Trial for COVID-19 Patients with Mild to Moderate Indications and a Second Randomized Protocol for All COVID-19 Patients in Severe Condition Will be Filed Next Week per FDA Recommendation

March 27, 2020 Comments Off on CytoDyn Files FDA-Suggested Modifications to IND and Protocol for Phase 2 Clinical Trial for COVID-19 Patients with Mild to Moderate Indications and a Second Randomized Protocol for All COVID-19 Patients in Severe Condition Will be Filed Next Week per FDA Recommendation
(OTC: CYDY) Leronlimab Used in Seven Patients with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU, Removed from ICU and Extubated with Reduced Pulmonary Inflammation

March 27, 2020 Comments Off on (OTC: CYDY) Leronlimab Used in Seven Patients with Severe COVID-19 Demonstrated Promise with Two Intubated Patients in ICU, Removed from ICU and Extubated with Reduced Pulmonary Inflammation

Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.